- Home
- Publications
- Publication Search
- Publication Details
Title
Atrial Fibrillation and Cancer Patients: Mechanisms and Management
Authors
Keywords
-
Journal
Current Cardiology Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-17
DOI
10.1007/s11886-022-01769-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
- (2022) Hussein A. Tawbi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of radiation on inpatient outcomes in patients with breast cancer and atrial fibrillation: A nationwide analysis
- (2022) Udhayvir Singh Grewal et al. HEART RHYTHM
- Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis
- (2022) Minha Murtaza et al. Frontiers in Cardiovascular Medicine
- Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
- (2021) Ellen K. Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Radiation Therapy May Be Associated With Atrial Fibrillation
- (2021) Nachiket Apte et al. Frontiers in Cardiovascular Medicine
- Postoperative atrial fibrillation in pneumonectomy for primary lung cancer
- (2021) Hao Wang et al. Journal of Thoracic Disease
- Mechanisms of Cardiovascular Toxicities Associated with Immunotherapies
- (2021) Alan Baik et al. CIRCULATION RESEARCH
- Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies
- (2021) Hussein A. Abbas et al. Frontiers in Oncology
- Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
- (2021) Michael G. Fradley et al. CIRCULATION
- Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
- (2021) John C. Byrd et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents
- (2021) Vijay U. Rao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018
- (2021) Yoshihiro Tanaka et al. Journal of the American Heart Association
- Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology
- (2021) Eve Belzile‐Dugas et al. Journal of the American Heart Association
- Atrial Fibrillation after Lung Cancer Surgery: Prediction, Prevention, and Anticoagulation Management
- (2021) Gennaro Semeraro et al. Cancers
- Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification
- (2021) Carmen Bergom et al. JACC: CardioOncology
- Risk of Atrial Fibrillation According to Cancer Type
- (2021) Jun Pil Yun et al. JACC: CardioOncology
- Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer
- (2021) Lauren E. Carlson et al. JACC: CardioOncology
- Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis
- (2021) Avirup Guha et al. EUROPEAN HEART JOURNAL
- Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
- (2020) Nicolas Palaskas et al. Journal of the American Heart Association
- Progress in cancer mortality, incidence, and survival
- (2020) Claudia Santucci et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment
- (2020) Yehia Saleh et al. HEART FAILURE REVIEWS
- ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2020) Paolo Ghia et al. JOURNAL OF CLINICAL ONCOLOGY
- Select Drug-Drug Interactions With Direct Oral Anticoagulants
- (2020) Barbara S. Wiggins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
- (2020) Jeff P Sharman et al. LANCET
- Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- (2020) Joerg Herrmann Nature Reviews Cardiology
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
- (2020) Ashley Chen et al. Journal of the American Heart Association
- Ibrutinib-Mediated Atrial Fibrillation Due to Inhibition of CSK
- (2020) Ling Xiao et al. CIRCULATION
- Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
- (2020) Paulus Kirchhof et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2020) Jinjin Wang et al. Frontiers in Pharmacology
- Anticoagulation Strategies in Patients With Cancer
- (2019) Ramya C. Mosarla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation
- (2019) Douglas L. Packer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs
- (2019) Ghansham S. More et al. Anti-Cancer Agents in Medicinal Chemistry
- Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared to Cytotoxic Chemotherapy
- (2019) Michael G. Fradley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies
- (2019) Isaac B. Rhea et al. Current Oncology Reports
- Atrial Fibrillation After Gastrointestinal Surgery: Incidence and Associated Risk Factors
- (2019) Emily G. Heywood et al. JOURNAL OF SURGICAL RESEARCH
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- A population-based study of cardiovascular disease mortality risk in US cancer patients
- (2019) Kathleen M Sturgeon et al. EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Catheter Ablation for Atrial Fibrillation with Heart Failure
- (2018) Nassir F. Marrouche et al. NEW ENGLAND JOURNAL OF MEDICINE
- CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer
- (2018) Maria D’Souza et al. European Journal of Preventive Cardiology
- Atrial Fibrillation and Risk of Cancer: A Danish Population‐Based Cohort Study
- (2018) Nicklas Vinter et al. Journal of the American Heart Association
- Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
- (2018) Christina L. Fanola et al. Journal of the American Heart Association
- Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer
- (2018) Wesley T. O’Neal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
- (2017) Jennifer R. Brown et al. HAEMATOLOGICA
- Risk of Arterial Thromboembolism in Patients With Cancer
- (2017) Babak B. Navi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
- (2017) Jennifer R. Brown et al. HAEMATOLOGICA
- Prognostic Significance of New-Onset Atrial Fibrillation in Patients With Non-Hodgkin's Lymphoma Treated With Anthracyclines
- (2016) Michitaka Amioka et al. AMERICAN JOURNAL OF CARDIOLOGY
- Autologous stem cell transplant for multiple myeloma patients 70 years or older
- (2016) E Muchtar et al. BONE MARROW TRANSPLANTATION
- Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders
- (2016) Stephen P. Mulligan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Shared Risk Factors in Cardiovascular Disease and Cancer
- (2016) Ryan J. Koene et al. CIRCULATION
- Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
- (2016) Andreas Zirlik et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Cardiovascular disease in cancer survivors
- (2016) Tochi M Okwuosa et al. POSTGRADUATE MEDICAL JOURNAL
- Surgical outcomes associated with postoperative atrial fibrillation after robotic-assisted pulmonary lobectomy: retrospective review of 208 consecutive cases
- (2016) Emily P. Ng et al. Journal of Thoracic Disease
- Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation
- (2016) David Conen et al. JAMA Cardiology
- Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)
- (2015) Wesley T. O'Neal et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pharmacokinetics of low molecular weight heparin in patients with malignant tumors
- (2015) Nicola J. Nasser et al. ANTI-CANCER DRUGS
- Arrhythmias in the setting of hematopoietic cell transplants
- (2015) E S Tonorezos et al. BONE MARROW TRANSPLANTATION
- PD-1/PD-L1 expression on CD4+T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation
- (2015) Li Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
- (2015) Renate B Schnabel et al. LANCET
- Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?
- (2014) Andreas Clemens et al. ANNALS OF MEDICINE
- Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy
- (2014) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atrial Fibrillation as a Marker of Occult Cancer
- (2014) Eva B. Ostenfeld et al. PLoS One
- Incidence of Supraventricular Arrhythmias during Autologous Peripheral Blood Stem Cell Transplantation
- (2013) Abhishek Singla et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prior Cancer in Patients with Ischemic Stroke: The Bergen NORSTROKE Study
- (2013) Henriette A. Selvik et al. Journal of Stroke & Cerebrovascular Diseases
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- Melphalan-Induced Supraventricular Tachycardia: Incidence and Risk Factors
- (2011) Victor Feliz et al. CLINICAL CARDIOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database
- (2010) Mark Onaitis et al. ANNALS OF THORACIC SURGERY
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
- (2010) Isabelle C. Van Gelder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
- (2009) David R Holmes et al. LANCET
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started